While the common types of non-small-cell lung cancer (NSCLC) are well known, there are other types of NSCLC that are less common and seldom encountered in the clinical routine. Sarcomatoid, salivary gland-type, and other/unclassified carcinomas are included in rare epithelial entities. In ...
NSCLC is the most common type of lung cancer; combined with small cell lung cancer, it affects more than 200,000 people in the United States each year. “The Lung-MAP trial has already proven its value by successfully completing trials with new targeted agents in selected, mole...
GILOTRIF is a prescription medicine that is used to treat people with non- small cell lung cancer (NSCLC) that: has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. ...
NSCLC may often produce few to no symptoms in early stages. In approximately 55% of people, the cancer has metastasized to distant parts of the body at the time of diagnosis. The symptoms of NSCLC depend on the location of the primary tumorand the regions of metastasis. The most common sy...
Additionally, patients with cancer stage IV have 11.47 times the odds of experiencing irAEs (OR: 11.47, 95% CI: 1.05–24.17). In conclusion, a substantial proportion of patients receiving ICIs experienced irAEs. Patients with an ECOG-PS score of ≥ 2 and advanced cancer stage are at ...
types of cancer: metastatic colorectal cancer; recurrent or metastatic non-squamous non-small cell lung cancer (nsNSCLC); recurrent glioblastoma; metastatic renal cell carcinoma; persistent, recurrent, or metastatic cervical cancer; and epithelial ovarian, fallopian tube, or primary peritoneal cancer. ...
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. Adding cetuximab to standard chemotherapy results in a moderate increase of overall survival in patients with advanced non-small-cell lung cancer (NSCLC), ... Joerger,Ma...
Non—small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma are among the most common types of lung cancer. There are also a few less prevalent lung cancer types that originate in the lung and chest wall. Most rare lung cancers are secondary to metastasis. These ...
EP: 5.Use of Sotorasib in Patients with KRASG12C mutated NSCLC EP: 6.Potential Shift of KRASG12C Inhibitors to the Front-line Setting EP: 7.Advice for Community Oncologists who Treat Patients with NSCLC LUNG CANCER | Precision Medicine ...
Learn about TAGRISSO® (osimertinib), a targeted therapy for patients with certain types of EGFRm non-small cell lung cancer (NSCLC).